|
Joshua C. Bunger |
|
|
Joshua C. Bunger |
|
|
|
Advanced Concentration |
Immunology & Microbiology | |
|
Mentor |
Maureen M. Goodenow, Ph.D. | ||
|
Department |
|||
|
Enrolled |
August 2003 |
||
|
Lab Room |
CGRC 280 | ||
|
Lab Phone |
273-8181 | ||
|
|
|||
|
Education |
|||
|
B.A., Biology, Grinnell College |
|||
|
Dissertation Research |
|||
| Multiple determinants within HIV-1 Gag-Vif are responsible for a novel post-entry restriction in macrophages | |||
|
|
|||
|
Publications |
|||
| Ho SK, Coman RM, Bunger JC, Rose SL, O'Brien P, Munoz I, Dunn BM, Sleasman JW, Goodenow MM. Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. Virology. 2008 Sep 1;378(2):272-81. Epub 2008 Jul 2. PMID: 18599104 abstract | |||
|
|
|||
last revised 11/12/09 tr
